The tests are Quidel’s QuickVue and Abbott’s BinaxNOW. Both allow users to swab themselves at home and get results in minutes. Quidel’s test takes 10 minutes to get results, and Abbott’s takes 15 minutes.
Testing advocates told The Hill the authorizations are a major breakthrough because the tests are simple, don’t require a prescription and can be mass-produced by the two companies.
A spokesperson for Abbott told The Hill the company can make tens of millions of tests per month and plans to begin shipping them to major food, drug and mass merchandise retailers within weeks.
Read the full article here.
More articles on supply chain:
Former White House adviser pursued his own medical supply contracts, report finds
California Nurses Association endorses state law requiring hospitals to keep 3-month PPE stockpiles
Bioventus acquires California devicemaker for up to $110M
